Background In stepped-care models patients typically start with a low intensity evidence-based treatment. Progress is monitored systematically and those patients who do not respond adequately step up to a subsequent treatment of higher intensity. Despite the fact that many guidelines have endorsed this stepped care principle it is not clear if stepped care really delivers similar or better patient outcomes against lower costs compared to other systems. We performed a systematic review and metaanalysis of all randomised trials on stepped care for depression.
Introduction

1
It is generally acknowledged that care for depression could be improved because the delivery and uptake 2 of antidepressant medication and evidence-based psychotherapies is often suboptimal (Simon, 2002; Bijl 3 et al. 2003; National Institute for Health and Clinical Excellence, 2011; Piek et al. 2011; Piek et al. 2012) . 4
Improvement of care is more likely to come from changes in the way care is provided than from adding 5 new treatment options (Katon & Unutzer, 2006) . 6
Currently, the standard approach in which mental health care is delivered to patients is called 7 matched care. In this approach the patient is referred to a certain therapist or therapy. The therapy 8 choice is based (matched) on patients' characteristics and preferences. As a result, the treatment may 9 vary (e.g. antidepressant medication or different types of psychotherapy) as well as the setting (primary 10 care, mental health care, online therapy, group therapy, individual therapy) and the provider (e.g. GP, 11 nurse, PWP, psychologist, psychiatrist). A major problem with this model at present is our lack of clear 12 prognostic determinants with which to match patients to the available treatments. It has been argued 13 that some patients receive too much treatment (Lovell & Richards, 2000) , whilst others too little, as 14 those lucky enough to be given treatment utilise highly scarce resources to the detriment of many others 15 who receive little or nothing. 16 An alternative approach is called 'stepped care'. Within the last ten years and in the context of 17 international concern regarding the cost and prevalence of common mental health problems, stepped 18 care has been recommended as a means to increase access and efficiency of mental health care 19 (Andrews et al. 2006; NICE, 2009) . In stepped-care models, the default position is that patients start with 20 an evidence-based treatment of low intensity as a first step. Progress is monitored systematically and 21 those patients who do not respond adequately will step up to a subsequent treatment of higher intensity 22 (Bower & Gilbody, 2005) . Low-intensity treatments are usually defined as those treatments that require 23 less time from a professional than a conventional treatment (Bennett-Levy et al. 2010) . However, 24 intensity may also mean the time required of patients, cost, and therapists' level of expertise and it is 25 possible for treatments to differ in one but not all of these dimensions. Patients, for example, may 26 themselves spend similar amounts of time undertaking high-or low-intensity treatments which require a 27 different amount of time from a professional. 28
Whilst the concept of intensity readily applies to psychological therapies, it is difficult to 29 characterise pharmacological and, perhaps, physical treatments as intensive or otherwise. Given the 30 widespread use of pharmacotherapy alongside psychological treatment for depression, it is perhaps 31 unsurprising that the term 'stepped care' is also used to refer to treatment that is not organised in order 1 of increased intensity; at each 'step' patients switch or add treatments of different modalities 2 (pharmacological, psychological) -patients may start with intensive psychological therapy (Araya et al. 3 2003; Katon et al. 2004; Ell et al. 2008) . 4
In practice, self-help treatments (through books or the internet) are often used as a first step in 5 stepped care. The effectiveness of self-help for depression, guided by a mental health worker but still of 6 less intensity than traditional psychological therapy, has been demonstrated convincingly (Gellatly et al. 7 2007; Andrews et al. 2010; Cuijpers et al. 2010; Richards & Richardson 2012) . Therefore, the assumption 8 of stepped care is that for most patients the low intensity treatment will be sufficient and only few will 9 need a higher intensity treatment, thereby making better use of scarce and expensive resources such as 10 therapist time. Many depression treatment guidelines have endorsed this stepped care principle e.g. the 11
English NICE guideline (NHS National Institute for Health and Clinical Excellence, 2009; National 12 Collaborating Centre for Mental Health, 2010) , and the Dutch multidisciplinary guideline (Spijker et al. 13 2010) . This has also led to implementing stepped care in routine practice. The most notable initiative in 14 this respect is the implementation of the Improving Access to Psychological Therapies (IAPT) programme 15 (www.iapt.nhs.uk), for which stepped care underpins the organisational structure. 16
The question remains how much evidence there is for the effectiveness of stepped care. Does 17 stepped care really deliver similar or better patient outcomes compared to other systems? Although, 18 observational data from the first year of English IAPT services show that recovery rates were higher in 19 services making use of the full range of low and high-intensity treatments in stepped care systems (Clark, 20 2011 ) no systematic review of randomised trials has been published yet. Therefore, our aim in this study 21 was to conduct a systematic review and meta-analysis of studies investigating the effectiveness of 22 stepped care for depression. 23
24
Methods
26
Search strategy 27
We carried out a comprehensive literature search in PubMed, PsycINFO, EMBASE, and the Cochrane 28 without any language restrictions and followed up identified protocol papers published before April 2012 1 to determine if the researchers had subsequently published their findings before May 2013. Two 2 independent researchers (AvS and JH) reviewed all abstracts and titles of retrieved references for 3 eligibility. We retrieved the full papers for all references that had been judged as potentially eligible and 4 the full papers were examined independently by two of the research team (AvS, JH, DR). In case of 5 disagreement the paper was discussed with the third reviewer until a consensus was achieved. We also 6 checked the reference lists of the included papers and a recent meta-analysis on collaborative care 7 (Archer et al. 2012) . 8 9
Inclusion criteria 10
We used the following inclusion criteria: (1) the study had to be a randomized controlled trial (2) aimed 11 at adults (3) with a DSM-IV depressive disorder identified through a diagnostic interview, or with 12 depressive symptoms established by scoring above a cut-off on a depression questionnaire, (4) 13 investigating 'stepped care' as one of the randomised trial groups. Stepped care had to include 14 psychological therapy and was defined as the availability of more than one psychological treatment of 15 different intensities and/or the availability of more than one treatment modality (pharmacological and 16 psychological). We defined the intensity of psychological treatments with respect to the time to deliver; 17 non-psychological (pharmacological) treatments were not characterised in this respect. We did not 18 require treatments to be organised in a hierarchy of low-to high-intensity. Decisions about stepping up 19 had to be based on a systematic clinical evaluation undertaken by a clinician or through questionnaire 20 assessment, done at a pre-specified time interval and with an explicit aim to determine the next 21 treatment step. We included studies in which only a proportion of patients were depressed, for example 22 studies including patients with a common mental health disorder and a sub-group of patients specifically 23 diagnosed with depression. We allowed both physical and psychiatric comorbidity. Studies were 24 included regardless of their setting or control group. 25
26
Data extraction 27
We coded the following general characteristics of the studies: year of publication, country, 28 randomisation level (patient or cluster), the way depression or depressive symptoms were established 29 (e.g. diagnostic interview or scoring above a cut-off on a questionnaire), possible comorbidity as an 30 inclusion criterion (e.g. cancer patients, diabetes), age, and total number of patients included in the 31 study. The stepped care interventions were coded as follows: number of steps, the content of the 1 interventions in the different steps, criteria to step up, and total duration of the program. Two 2 independent assessors coded each study and differences were discussed among the review team until 3 consensus was reached. 4 5
Quality assessment 6
We assessed the validity of the studies using the criteria as suggested by the Cochrane Handbook (The 7
Cochrane Collaboration, 2011): adequate sequence generation, concealment of allocation, blinding of 8 outcome assessors, adequate handling of incomplete outcome data, selective reporting of data and 9 other potential threats to validity. Two reviewers conducted the quality assessment independently of 10 each other. 11 12
Meta-analyses 13
We calculated between group effect sizes (Cohen's d) for all individual studies. The effect size represents 14 the difference between two groups in number of standard deviations (Hedges & Olkin, 1985; Cooper & 15 Hedges, 1994) . To calculate between group effect sizes we used the available statistics as published in 16 the papers (means and standard deviations, mean difference score and 95% confidence interval, or 17 proportions of patients improved or recovered). When more than one outcome was reported (e.g. more 18 than one depression questionnaire or more than one cut-off score) we performed a sensitivity analysis. 19
We pooled the effects using (a) the highest reported effect sizes for all studies and (b) the lowest 20 reported effect sizes for all studies and (c) the average or combined effect size for all studies. 21
To calculate the individual effect sizes as well as the pooled mean effect size we used the 22 computer program Comprehensive Meta-analysis version 2.2.046 for Windows, developed for support in 23 meta-analysis (www.metaanalysis.com). As we expected considerable heterogeneity, we calculated 24 pooled effect sizes with the random effects model. However, we first tested heterogeneity under the 25 fixed effects model using the statistics I 2 and Q. I 2 describes the variance between studies as a proportion 26 of the total variance. A value of 0% indicates no observed heterogeneity, and larger values show 27 increasing heterogeneity, with 25% as low, 50% as moderate, and 75% as high heterogeneity. The 28 statistical significance of the heterogeneity is tested with the Q statistic. A significant Q value rejects the 29 null hypothesis of homogeneity. We mark all results in which the p-value is lower than 0.05. 30
In addition, we performed subgroup analyses. In these analyses we tested whether there were 1 significant differences between the effect sizes in different categories of studies. We used the mixed 2 effects model, which pools studies within subgroups with the random effects model, but tested for 3 significant differences between subgroups with the fixed effects model. Lastly, publication bias was 4 tested by inspecting the funnel plot, and by Duval and Tweedie's trim and fill procedure, which yields an 5 estimate of the effect size after publication bias has been taken into account (as implemented in 6
Comprehensive Meta-analysis; Duval & Tweedie, 2000) . 7 8
Results
10
Inclusion of studies 11
We retrieved 61 manuscripts for eligibility after screening 438 references (Figure 1 ). We excluded 47 of 12 the 61 that did not fulfill our inclusion criteria. In total, we included 14 studies on stepped care for 13 depression (Unutzer et al. 2002 [13] authors to obtain the (unpublished) research protocol and additional data. 18
We included ten of the 14 studies in our quantitative meta-analyses on the treatment of 19 depression in which outcomes were expressed as the reduction of depressive symptoms. One treatment 20 trial was excluded from this analysis because the authors did not report post-treatment data but only 21 long-term follow-up. The three remaining trials were aimed at prevention of depression, either as 22 indicated prevention [6, 14] or as relapse prevention [1] with the incidence of depressive disorders as the 23 main outcomes. Given that it is not useful to pool results from treatment and prevention we excluded 24 the prevention trials from our quantitative meta-analyses. 25
26
Characteristics of the 14 included treatment and prevention studies 27
The 14 studies included a total of 5,194 patients of whom 2,560 were randomized to stepped care and 28 2,634 to a control condition. For the ten studies included in the quantitative meta-analyses the total 29 number of included patients is 4,580 with 2,243 in the stepped care arms and 2,337 in the control 30 conditions (Table 1) . 31
Twelve trials were patient-randomised [1] [2] [3] [4] [5] [6] [7] [8] 10, [12] [13] [14] , and two were cluster-randomised [9, 11] . 1 Six trials were conducted in the US [4] [5] [7] [8] 10, 13] , six in The Netherlands [1, 3, 6, 9, 12, 14] , one in Chile [2] 2 and one in India [11] . Participants were recruited mainly from primary care [2, [9] [10] [11] [12] [13] [14] , or secondary 3 care [3] [4] [5] 7] . All studies compared stepped care to usual care, either standard [1] [2] [3] [4] [5] [6] [9] [10] [12] [13] [14] or 4 'enhanced' [7] [8] 11] . 5
Five of the treatment trials [3] [4] [5] 8 ,10] included patients scoring above a cut-off on a self-rated 6 depression questionnaire only (two also used the core symptoms of MDD) while five others [6,9,11-13] 7 performed diagnostic interviews to include patients with MDD (one also included minor depression, and 8 two also included dysthymia). The three prevention trials [1,6,14] used a diagnostic interview to exclude 9 patients with MDD. Six of the studies were aimed at depressive symptoms among patients with either 10 co-morbid acute coronary syndrome [4] [5] , cancer [7] or diabetes mellitus [3, 8, 10] and five trials, 11 including the three prevention studies, were specifically aimed at older adults [1, 3, 6, 13, 14] . 12 13
Characteristics of the stepped care interventions 14
We found considerable between study heterogeneity in numbers of steps (two, three or four), types of 15 treatments offered at each step, and duration of the total intervention (between three and 12 months; 16 table 2). 17
Seven studies [4, 5, [7] [8] [9] [10] 13] , six of which were US trials, were based on the 'IMPACT' model and 18 used Problem Solving Treatment (PST) and antidepressant medication (ADM) as the core of the 19 intervention. The IMPACT intervention is primarily a collaborative intervention in which a dedicated 20 team works together to provide optimal depression care, meeting our inclusion criteria as a stepped care 21 approach because patients were evaluated at predetermined time intervals according to defined 22 improvement criteria and care was adjusted or augmented if the patient did not improve sufficiently. 23
Treatments were provided according to patients' needs and preferences. In all seven 'IMPACT' studies 24 and one other involving both psychological treatment (psycho-education) and ADM [2], there was no 25 progression of increasing therapeutic intensity. 26
In contrast, care was delivered in the other six trials [1, 3, 6, [11] [12] 14 ] through steps of increasing 27 intensity. Five of the six studies started with watchful waiting although two studies [12, 14] only included 28 patients after the watchful waiting period while the other three [1, 3, 6] included watchful waiting as part 29 of their stepped care model. The first therapeutic component included psycho-education or 30 bibliotherapy alone or combined, offered either as self-help (with online, telephone or face-to-face 31 support), in a group, or as individual sessions. The next step in these six studies varied widely and 1 included psychological therapy (CBT, life review, IPT, PST, Coping with Depression Course) [1, 3, 6, 12, 14 ] 2 or a psychological therapy (IPT) combined with ADM [11] . The last step typically consisted of referral to 3 specialists, a GP or mental health services. Only two of those six studies which used steps of increasing 4 intensity are included in the quantitative meta-analysis [11, 12] . As mentioned above, one study was 5 excluded because of unavailability of post-test data [3] , and the three other trials were aimed at 6 (relapse) prevention [1, 6, 14] . 7
In twelve studies more than one healthcare professional was involved in stepped care [1-2,4-13] 8 including nurses [1] [2] [4] [5] [6] 10, [12] [13] , psychiatrists [4] [5] [7] [8] [9] [10] [11] 13] , General Practitioners [2, 5, 8, 9, 11, 13] only [14] . No details are available for external professionals providing treatment after referral outside 13 the core stepped care team. 14 Patient progress was assessed using one [1] [2] [3] [4] [5] [6] [7] [9] [10] [11] [13] [14] 
Quality of the included studies 23
In one study [3] we rated all quality criteria as either unclear or at high risk of bias and in a second [1] we 24 rated five of the six criteria as unclear or at high risk of bias. For the remaining twelve studies quality on 25 most criteria was high. The description of randomisation sequence generation was adequate but four of 26 these twelve studies did not clearly report methods of allocation concealment [4, 10, 11, 14] . No studies 27 were able to blind patients or clinicians but all studies used assessors to measure outcomes who were 28 unaware of the randomisation status of the patients or used self-report. Post-intervention study drop-29 out ranged between 8.0% [5] and 49.6% [3] and one study [9] was rated at high risk of bias with respect 30 to handling incomplete outcome data. All studies used intention-to-treat analyses. Three of the twelve 31 studies were at high risk of other biases because of the potential for contamination between trial arms 1 [6, 8, 13] or because patients were recruited in different ways in the intervention and control groups [9] . 2 3 Effects of stepped care 4
Most of the studies used more than one depression outcome measure so we averaged the between 5 group differences from the various measures as a single combined measures effect size for each study 6 (Table 3) . We found an overall post-intervention effect size of d = 0.38 (95% CI 0.18 to 0.57). We also 7 examined the post-test effect sizes from the measure with the highest effect size for each study (d = 8 0.42; 95% CI 0.22 to 0.62) and repeated this with the measure producing the lowest effect sizes (d = 9 0.33; 95% CI 0.13 to 0.52). All effect sizes were significantly in favour of stepped care. 10
The stepped care interventions varied in duration between three and 12 months. We used the 
Subgroup analysis and publication bias 20
We analysed the association of the six months outcomes (overall d = 0.34; Table 3 ) with the following 21 variables: country in which the study was performed (USA, Netherlands, or other), treatment based on 22 IMPACT protocol (yes or no), stepped care treatment using progressive intensity (yes or no), physical 23 health comorbidity (present or absent), and diagnostic status at inclusion (diagnosis assessed or not). 24
The effect of the eight studies on stepped care models without progressive intensity was significantly 25 higher (d=0.41) than those of the two studies examining stepped care models with progressive intensity 26 (d=0.07; p < 0.01). None of the remaining variables were significantly related to the effect size. Even 27 though not statistically significant (p=0.63) the effect size for the two Dutch studies was lower (d=0.18) 28 than for those conducted in the USA (d=0.38) or other countries (d=0.44). 29
We found no indication of publication bias in our funnel plot on the six month outcomes or in 30
Duval and Tweedie's trim and fill procedure. No studies needed to be imputed. Even though we demonstrated that stepped care is effective, the effect sizes were modest. This finding may not be suprising given that six out of the ten studies [2,7 8,10,11,13] included in our 4 meta-analysis were also included in the meta-analysis of collaborative care. 5
In stepped care the primary focus is on psychological interventions of different intensity. 6
However, as we noted in our introduction, it is unclear how medication management, which might be 7 offered with significant support from case managers, fits into stepped care programs. Since medication 8 management is an important treatment option in depression care, we decided to include it in our 9 definition of stepped care (the availability of more than one treatment modality, medication and 10 psychotherapy). This choice led to the inclusion of several of the collaborative care trials, albeit the 11 majority of which were also described as stepped care [2, 7, 8, 10, 11] , and three other studies [4, 5, 9] in 12 which stepped care was not defined by a progressive increase in treatment intensity. Our definition is 13 debatable: others may choose to review or conduct future research on stepped care in line with how it 14 was originally conceived; findings based on one definition of stepped care may not generalize to the 15 other; future research may be required to compare stepped care defined by a progressive increase in 16 treatment intensity and stepped care that is not. 17
We compared the results of the eight studies without a hierarchy in treatment intensity with the 18 two studies which did provide 'true' stepped care with increasing treatment intensity. This comparison 19 demonstrated that the 'true' stepped care studies performed significantly worse. This indicates that it 20 might be better to match the first treatment to the patient's need than to offer a low intensity treatment 21 regardless of the patient's clinical profile. However, we think that this conclusion would be premature. 22
First, because the results of 'true' stepped care are based on two studies only. Second, because seven of 23 the eight studies without increasing intensity were based on the IMPACT protocol. Those seven IMPACT 24 studies did not show better results than the three non-IMPACT studies. In other words, the difference in 25 results between the two subgroup analyses (IMPACT vs. non-IMPACT, and increasing intensity vs. no 26 increasing intensity) was actually based on one study with a very high effect size [2] . Third, because the 27 two studies aiming at prevention of (indicated) depression both offered 'true' stepped care and they 28 demonstrated very large effects (almost halving the incidence of depression). In conclusion we think that 29 more 'true' stepped care studies need to be performed before we can reach a definite conclusion. 30
Moreover, it is important not only to look at treatment studies but also prevention studies especially as 31 it has been argued that prevention contributes most in reducing the global burden of depression 1 (Cuijpers et al. 2012 ). This and other key areas for future research are summarised in Box 1. 2
The central tenet of stepped care is that for many patients the first (low intensity) treatments 3 are sufficient and relatively few patients need to step up. This means that similar (or better) patient 4 outcomes could be achieved against lower costs. In the current meta-analyses only a limited number of 5 trials provided data on the proportion of patients recovered after the first treatment. The data that was 6 available was hard to interpret since the definition of adequate recovery varied between the studies as 7 well as the duration of the steps, the number of patients dropping out of treatment and the number of 8 patients not reporting health status. We also do not know how many patients needed to step up or the 9 actual percentage of patients who took up this second step. This is important information because within 10 stepped care there is a risk that patients do not start a second higher intensity treatment after failure of 11 the first. To improve reporting on clinical trials of stepped care for depression, we identify data that are 12 important to include (Box 2); including this would maximize subsequent systematic reviews. 13
We did demonstrate that better outcomes were reached in stepped care compared to care-as-14 usual. However, the question is whether or not care-as-usual is the best comparator. One could argue 15 that care-as-usual is similar to matched care since this is the current dominant treatment approach. 16
However, all the trials used an active approach to find and select patients. In four trials it was reported 17 that the GP was informed about the diagnostic status of the patients in the control group, while the 18 other studies refrained from informing the GP or did not report how they handled this. This indicates 19 that care-as-usual probably more closely resembled 'no care'. In other words we demonstrated that 20 stepped care is better than doing nothing. The ideal test, against true matched care or against high 21 intensity care for all patients, has not been performed yet. We identified five (Dutch) protocol 22 manuscripts on stepped care (Braamse et al. 2010; Krebber et al. 2012; Pommer et al. 2012; Van Dijk et 23 al. 2012; Van der Weele et al. 2012) ; none compare stepped with matched care or with intensive 24 psychological treatment for all. 25
The remaining assumption of stepped care is that it reduces health care costs. Six out of the ten 26 studies included in the meta-analyses published a separate paper on the cost-effectiveness of their 27 (collaborative) stepped care program (Katon et al. 2005; Araya et al. 2006; Simon et al. 2007 ; Van 't Veer-28 Tazelaar et al. 2010; Butorff et al. 2012; Hay et al. 2012; Ladapo et al. 2012 ). The results of the studies 29 performed in Chile and India are hard to generalize to the Western world. The remaining four (US) 30 papers either report savings or incremental costs which are offset by the health gains. This means that 31 there is an indication that stepped care interventions might indeed be more cost-effective. However, 1 because stepped care has not been compared to either matched care or high intensity care, final 2 conclusions about cost-effectiveness cannot be made. 3
Our study has several limitations. First is the limited number of studies. This made it especially 4 hard to perform subgroup analyses. In this respect, the five protocol manuscripts on stepped care are 5 relevant, indicating that there is considerable clinical trials work in progress. Second, the stepped care 6 interventions varied a lot as well as the samples included in the studies (countries, with or without 7 comorbidity, age, definitions of depression etc). This may limit the generalizability of our findings. A 8 strength of this study is that it is the first to systematically describe all the available evidence with 9 respect to stepped care which is regarded in many countries as the preferred way to offer depression 10 care. Furthermore, most of the studies were of good quality. 11
Although many guidelines recommend stepped care, there is currently only limited evidence to 12 suggest it should be the dominant model of treatment organization compared to alternative systems. 13
Consistent with a previous observational study (Richards et al. 2012) , we found considerable variety in 14 the implementation of stepped care (with respect to the number and duration of treatment steps, 15 treatments offered, professionals involved and criteria to step up) and only one significant difference 16 between subgroups of studies (progressive intensity, yes/no) which requires further research. Hence, it 17 was not possible to identify any optimal component of stepped care or to suggest a preferred model for 18 delivery which may be associated with increased effectiveness. 
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